date:Apr 15, 2013
and high biological costs, the company said in its statement. The result in Chile further underlines the requirement for consolidation in the Chilean industry.
But the news wasnt all bad. For the whole company, operational EBIT was approximately NOK 480 million (USD 83.8 million, EUR 64.1 million), up significantly from the NOK 276 million (USD 48.2 million, EUR 36.9 million) recorded in 1Q 2012.
The company released early figures on volume as well. Between Norway, Chile, Canada, Scotland, an